Technology commercialization and market entry
From laboratory to market, and across borders.
Innovation creates value only when it reaches the patients, programs, and markets that need it. We provide the market intelligence, regulatory navigation, and partnership support that help technology developers move validated concepts toward deployment, in the United States and abroad.
What we provide
U.S. market entry strategy for international technologies
Assessment of regulatory pathway options and market opportunity, FDA framework guidance, study design, and identification of U.S. commercial partners.
Regulatory pathway and FDA strategy
Pathway analysis for diagnostics, therapeutics, biologics, and combination products, including pre-submission preparation, regulatory document preparation, and response strategy for FDA feedback.
Market analysis and commercial strategy
Competitive landscape, stakeholder interviews, reimbursement pathways, distribution channels, pricing, and go-to-market planning specific to health technology.
Partner identification and business development
Introductions, negotiation support, partnership structuring, and relationship management across the federal, academic, and commercial health technology ecosystem.
International market expansion for U.S. technologies
Regulatory intelligence, international distribution partners, and expansion sequencing, with insight into health technology markets in Africa, Southeast Asia, and Latin America.
Contracting officers and program managers
Tell us about your requirement. We respond by email and can provide a capability statement on request.